Sign in

CIK 0001527753

  • Non-accelerated filer
  • Smaller reporting company

Personalis, Inc.

Sign in to watch
Ticker
PSNL
Exchange
Nasdaq
Industry
Services-Medical Laboratories
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
275411038
Phone
+1 650-752-1300
Business address
6600 DUMBARTON CIRCLE, FREMONT, CA, 94555
  1. 4 Open-market sale Chief Financial Officer sold 3,440 shares at $3.29 ($11,318)
  2. 4 Open-market sale General Counsel sold 1,832 shares at $3.24 ($5,936)
  3. 4 Open-market sale Chief Medical Officer sold 6,818 shares at $3.24 ($22,090)
  4. 4 Open-market sale Chief Financial Officer sold 6,818 shares at $3.24 ($22,090)
  5. 4 Open-market sale Chief Financial Officer sold 4,187 shares at $3.59 ($15,031)
  6. 4 Open-market sale Chief Medical Officer sold 421 shares at $3.59 ($1,511)
  7. 4 Grant or award Director acquired 10,770 shares (grant or award)
  8. 4 Grant or award Director acquired 10,770 shares (grant or award)
  9. 4 Grant or award Director acquired 10,770 shares (grant or award)
  10. 4 Grant or award Director acquired 10,770 shares (grant or award)
  11. 4 Grant or award Director acquired 10,770 shares (grant or award)
  12. 4 Grant or award Director acquired 10,770 shares (grant or award)
  13. 4 Open-market sale Chief Financial Officer sold 1,286 shares at $4.86 ($6,250)
  14. 4 Open-market sale President and CEO sold 2,408 shares at $4.86 ($11,703)
  15. 4 Open-market sale General Counsel sold 664 shares at $4.86 ($3,227)
  16. 4 Open-market sale Chief Medical Officer sold 1,286 shares at $4.86 ($6,250)
  17. 4 Open-market sale General Counsel sold 5,733 shares at $5.53 ($31,703)
  18. 4 Option exercise President and CEO acquired 45,061 shares (option exercise)
  19. 4 Open-market sale President and CEO sold 64,430 shares
  20. 4 Grant or award President and CEO acquired 54,347 shares (grant or award)

Page 8 of 15 · 289 filings